These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
465 related articles for article (PubMed ID: 27817758)
1. A Comprehensive Study of Costs Associated With Recurrent Clostridium difficile Infection. Rodrigues R; Barber GE; Ananthakrishnan AN Infect Control Hosp Epidemiol; 2017 Feb; 38(2):196-202. PubMed ID: 27817758 [TBL] [Abstract][Full Text] [Related]
2. Healthcare burden of recurrent Clostridioides difficile infection in Japan: A retrospective database study. Kunishima H; Ito K; Laurent T; Abe M J Infect Chemother; 2018 Nov; 24(11):892-901. PubMed ID: 30190105 [TBL] [Abstract][Full Text] [Related]
3. Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study. Shah DN; Aitken SL; Barragan LF; Bozorgui S; Goddu S; Navarro ME; Xie Y; DuPont HL; Garey KW J Hosp Infect; 2016 Jul; 93(3):286-9. PubMed ID: 27209056 [TBL] [Abstract][Full Text] [Related]
4. Mortality and Costs in Clostridium difficile Infection Among the Elderly in the United States. Shorr AF; Zilberberg MD; Wang L; Baser O; Yu H Infect Control Hosp Epidemiol; 2016 Nov; 37(11):1331-1336. PubMed ID: 27572289 [TBL] [Abstract][Full Text] [Related]
5. Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States. Zhang D; Prabhu VS; Marcella SW Clin Infect Dis; 2018 Apr; 66(9):1326-1332. PubMed ID: 29360950 [TBL] [Abstract][Full Text] [Related]
6. Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review. Gabriel L; Beriot-Mathiot A J Hosp Infect; 2014 Sep; 88(1):12-21. PubMed ID: 24996516 [TBL] [Abstract][Full Text] [Related]
7. Factors Associated with the Use of Fecal Microbiota Transplant in Patients with Recurrent Clostridium difficile Infections. Jamot S; Raghunathan V; Patel K; Kelly CR; Lim SH Infect Control Hosp Epidemiol; 2018 Mar; 39(3):302-306. PubMed ID: 29363436 [TBL] [Abstract][Full Text] [Related]
8. Hospital cost of Clostridium difficile infection including the contribution of recurrences in French acute-care hospitals. Le Monnier A; Duburcq A; Zahar JR; Corvec S; Guillard T; Cattoir V; Woerther PL; Fihman V; Lalande V; Jacquier H; Mizrahi A; Farfour E; Morand P; Marcadé G; Coulomb S; Torreton E; Fagnani F; Barbut F; J Hosp Infect; 2015 Oct; 91(2):117-22. PubMed ID: 26253518 [TBL] [Abstract][Full Text] [Related]
9. Attributable Cost of Clostridium difficile Infection in Pediatric Patients. Mehrotra P; Jang J; Gidengil C; Sandora TJ Infect Control Hosp Epidemiol; 2017 Dec; 38(12):1472-1477. PubMed ID: 29173236 [TBL] [Abstract][Full Text] [Related]
10. Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach. Desai K; Gupta SB; Dubberke ER; Prabhu VS; Browne C; Mast TC BMC Infect Dis; 2016 Jun; 16():303. PubMed ID: 27316794 [TBL] [Abstract][Full Text] [Related]
11. Cost analysis of an outbreak of Clostridium difficile infection ribotype 027 in a Dutch tertiary care centre. van Beurden YH; Bomers MK; van der Werff SD; Pompe EAPM; Spiering S; Vandenbroucke-Grauls CMJE; Mulder CJJ J Hosp Infect; 2017 Apr; 95(4):421-425. PubMed ID: 28169013 [TBL] [Abstract][Full Text] [Related]
12. Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era. Polage CR; Gyorke CE; Kennedy MA; Leslie JL; Chin DL; Wang S; Nguyen HH; Huang B; Tang YW; Lee LW; Kim K; Taylor S; Romano PS; Panacek EA; Goodell PB; Solnick JV; Cohen SH JAMA Intern Med; 2015 Nov; 175(11):1792-801. PubMed ID: 26348734 [TBL] [Abstract][Full Text] [Related]
13. Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection. Wiegand PN; Nathwani D; Wilcox MH; Stephens J; Shelbaya A; Haider S J Hosp Infect; 2012 May; 81(1):1-14. PubMed ID: 22498638 [TBL] [Abstract][Full Text] [Related]
14. The burden of healthcare-associated Clostridium difficile infection in a non-metropolitan setting. Bond SE; Boutlis CS; Yeo WW; Pratt WAB; Orr ME; Miyakis S J Hosp Infect; 2017 Apr; 95(4):387-393. PubMed ID: 28131640 [TBL] [Abstract][Full Text] [Related]
15. Predictors and burden of hospital readmission with recurrent Clostridioides difficile infection: a French nation-wide inception cohort study. Dinh A; Le Monnier A; Emery C; Alami S; Torreton É; Duburcq A; Barbier F Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1297-1305. PubMed ID: 30941532 [TBL] [Abstract][Full Text] [Related]
16. Impact of recurrent Clostridium difficile infection: hospitalization and patient quality of life. Wilcox MH; Ahir H; Coia JE; Dodgson A; Hopkins S; Llewelyn MJ; Settle C; Mclain-Smith S; Marcella SW J Antimicrob Chemother; 2017 Sep; 72(9):2647-2656. PubMed ID: 28633368 [TBL] [Abstract][Full Text] [Related]
17. Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year, single-centre cohort study. Ianiro G; Valerio L; Masucci L; Pecere S; Bibbò S; Quaranta G; Posteraro B; Currò D; Sanguinetti M; Gasbarrini A; Cammarota G Clin Microbiol Infect; 2017 May; 23(5):337.e1-337.e3. PubMed ID: 28057560 [TBL] [Abstract][Full Text] [Related]